In the role of the General Manager, Michael set up the Swiss affiliate from scratch at Portola Pharmaceuticals. Previously, he was the European Launch Leader for an orphan disease asset at Celgene and built and managed business units at Celgene and AbbVie. Michael held various management positions at Roche and Essex/MSD and spent several years as a management consultant at The Boston Consulting Group. Michael holds a Master of Science in medical microbiology and a PhD in immunology from the University of Bern. He completed training programs at the HSG, INSEAD and the LBS and holds an Executive MBA in General Management from the University of Zurich.
Board of Directors
Throughout his career, Bruno has applied his rigorous academic background in various knowledge-driven roles, including as current Head of Spent Fuel and Waste Management at Axpo Power, Switzerland’s largest energy provider. Comfortable in positions of responsibility, Bruno has also previously served as Head of Nuclear Fuels at a power plant. He holds a PhD in physics from the Swiss Federal Institute of Technology (ETH Zürich) and an executive MBA.
Besides consistently generating solid business results, Bruno has a strong track record in leadership, change management and efficient organization. Bruno is an experienced board member, and currently serves as Chairman of the Scientific Advisory Committee of the Laboratory for Nuclear Materials at Paul Scherer Institute. Previously he was Deputy Chairman of the Board of Directors of the pension fund PKE.
Motto: A wise man will make more opportunities than he finds (Francis Bacon).
Bruno Zimmermann, PhD EMBA
Member of the Board of Directors
Our purpose is to enable healthy lives through sowing and growing of medical breakthroughs in Switzerland.